RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma.
Liu Y, Cheng G, Song Z, Xu T, Ruan H, Cao Q, Wang K, Bao L, Liu J, Zhou L, Liu D, Yang H, Chen K, Zhang X.
Liu Y, et al. Among authors: liu j, liu d.
Int J Oncol. 2019 Sep;55(3):645-656. doi: 10.3892/ijo.2019.4849. Epub 2019 Jul 26.
Int J Oncol. 2019.
PMID: 31364727
Free PMC article.